Filed Chapter 11 (May 2025) to cut $1.15B debt as GLP-1 drugs gutted demand; stock under $1 before filing; emerged ~45 days later.
The rise & fall
9 moments · 1963–2025
The key moments, with employee sentiment along the way.
May 15 ’63
🌱
May 15 ’63
Founded in Queens
Jean Nidetch turns living-room weigh-ins into a points-and-meetings empire.
Wikipedia
Oct 2015
🦄
Oct 2015
Oprah buys in
Winfrey takes a roughly 10% stake and a board seat; the fading brand roars back past $1B.
CNBC
2018
📈
2018
The peak: stock tops $100$8B
The Oprah-era turnaround crests with a market value around $8B.
Bloomberg
2023
2023
Ozempic changes everything
GLP-1 drugs gut demand for diet programs; WW even buys a telehealth startup to prescribe them itself.
CNN
Feb 2024
Feb 2024
Oprah exits the board
The company's most famous backer steps away; the stock plunges.
CNN
2024
💔
2024
Falls out of the club
Revenue slides to about $811M as the drugs do what the diet used to; the market cap dwindles toward penny-stock territory.
SEC filing
2022–25
💬
From the inside · Glassdoor reviews, 2022–25
Glassdoor reviews traced the unraveling well before the filing: employees described years of near-continuous restructuring under a revolving door of senior leaders, layoffs landing two or three times a year, and frontline coaches watching workshops close, pay stagnate, and the 401(k) match disappear.
May 6 ’25
🪦
May 6 ’25
Chapter 11 — joins the Unitard Club 💔
A prepackaged filing wipes out $1.15B in debt, with the stock under $1 before the filing.
Bloomberg
2025
2025
Emerges from Chapter 11 in ~45 days
The slimmed-down company exits bankruptcy quickly, debt load cut.
Bloomberg
$7.9Bof peak value erased · 61 years
💬 entries paraphrase anonymous, unverified reviews posted publicly on Glassdoor ↗; dated facts carry their source.
How it happened
WeightWatchers, the weight-management brand behind points-based diet programs and group meetings, surged to renewed prominence after Oprah Winfrey invested in 2015, and its market value climbed above $8B by 2018.
GLP-1 drugs like Ozempic and Wegovy then gutted its core business; revenue slid to about $811M in 2024 and the stock fell under $1, and in May 2025 WW International filed a prepackaged Chapter 11 to wipe out $1.15B in debt.
Source: CNN / Bloomberg / SEC (stock peaked above $100 in 2018, market cap ~$8B; revenue fell to ~$811M in 2024 amid Ozempic/Wegovy disruption; Chapter 11 May 6 2025 to cut $1.15B debt)
